Comparison Between Two Concentration of Hypertonic Saline in Intestinal Obstruction Surgery

NCT ID: NCT03741257

Last Updated: 2018-11-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-11-01

Study Completion Date

2020-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background and Rationale :

Perioperative fluid management is a challenging issue in surgical care especially in a procedure specific model. Recently hypertonic saline (HS) has the advantage of using the patient's own total body water by drawing interstitial space. Although it still controversial whether HS is associated with benefits in specific patient populations, particularly with respect to site of lesion and illness severity; these data provide insight into therapeutic modalities to curtail ileus formation.

Objectives :

* Measurement of total volume of fluid infused, the need of inotropic or vasopressor to maintain adequate hemodynamic parameters with assessment of electrolyte disturbances and S.lactate
* The incidence rate of surgical complications; infection and anastomotic dehiscence

Study population \& Sample size :

There were no previous trials comparing the two studied groups of the current trial. We expected a small standardized effect size of 0.2. Based on this effect size, 25 subjects will be needed to elicit the difference between the two groups at an alpha level of 0.05 and power of 0.9 (Whitehead et al; 2016).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intestinal Obstruction Fluid Management With Hypertonic Saline

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A

Received Hypertonic saline 3% as resuscitation fluid.

Group Type ACTIVE_COMPARATOR

Hypertonic saline

Intervention Type DRUG

resuscitation fluid

Group B

Received Hypertonic saline 1.8% as resuscitation

Group Type ACTIVE_COMPARATOR

Hypertonic saline

Intervention Type DRUG

resuscitation fluid

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hypertonic saline

resuscitation fluid

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age: 20-70 years old
* ASA≤III
* BMI 25-40kg/m.

Exclusion Criteria

* Severe CVS diseases (EF\<50%)
* Severe pulmonary diseases (Pulmonary function test ≤ 50% of predicted)
* Neurological disorders; Psychological diseases, demyelinating lesions, Parkinsonism, motor or sensory disorders.
* Pregnancy.
* Severe chronic renal disease (s. Creatinine\> 2gm/dl or patients on dialysis).
* Severe hepatic impairment (Child \& Pugh classification class C).
* Acid-base and electrolytes disturbances.
Minimum Eligible Age

20 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ahmed Mohamed Lotfy

lecturer of anesthesia and intensive care

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cairo University Hospitals

Cairo, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Rasha Behery, MD

Role: CONTACT

+201228604556

Ahmed Lotfy, MD

Role: CONTACT

+201000608905

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ahmed Lotfy, MD

Role: primary

+201000608905

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

N-55-2018

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.